SmartCella Feed

2026-11-03 09:00:00 SmartCella signs Extroducer® license agreement with HeartWorks for precise delivery of cell therapies

2026-11-03 09:00:00 SmartCella tecknar licensavtal för Extroducer® med HeartWorks för precis leverans av cellterapier

2026-09-17 09:05:00 The Extroducer® 2.0 receives 510(k) clearance by the US FDA

2026-09-17 09:05:00 Extroducer® 2.0 får 510(k)-godkännande från amerikanska FDA

2026-09-09 09:30:00 SmartCella expands patent for the Extroducer® into the US and Japan

2026-09-09 09:30:00 SmartCella utökar patentskyddet för Extroducer® till USA och Japan

2026-06-23 17:00:00 SmartCella and Heqet Therapeutics enter into licensing agreement regarding the Extroducer® delivery platform

2026-06-23 17:00:00 SmartCella och Heqet Therapeutics ingår licensavtal avseende leveransplattformen Extroducer®

2026-05-22 10:30:00 SmartCella initiates Phase I/IIa clinical study with Extroducer® for targeted delivery of chemotherapy in pancreatic cancer

2026-05-22 10:30:00 SmartCella inleder klinisk fas I/IIa studie med Extroducer® för riktad leverans av cytostatika vid bukspottkörtelcancer

2026-05-07 09:00:00 SmartCella and Oloker enter Extroducer® licensing agreement, advancing targeted delivery strategy

2026-05-07 09:00:00 SmartCella och Oloker ingår licensavtal för Extroducer®, ett viktigt steg i strategin för riktade läkemedelsleveranser

2026-04-22 09:00:00 SmartCella publishes its 2025 Annual Report

2026-04-22 09:00:00 SmartCella publicerar årsredovisning för 2025

2026-04-21 16:00:00 Kallelse till årsstämma i SmartCella Holding AB

2025-11-13 09:00:49 SmartCella appoints Professor Jan Lundberg to Scientific Advisory Board

2025-07-11 09:30:00 Första patienten behandlad i XyloCor Therapeutics fas IIb-studie med SmartCellas leveransplattform Extroducer

2025-07-11 09:30:00 First patient dosed in XyloCor Therapeutics’ Phase IIb trial using SmartCella’s Extroducer delivery platform

2025-07-01 09:58:01 SmartCella bildar vetenskapligt råd med ledande globala vetenskapliga experter

2025-07-01 09:58:01 SmartCella forms Scientific Advisory Board with leading global scientific experts

2025-06-18 09:00:00 Kallelse till extra bolagsstämma i SmartCella Holding AB

2025-05-26 10:00:00 Procella obtains regulatory approval to widen the scope of cell therapy manufacturing for clinical stages

2025-05-26 10:00:00 Procella erhåller regulatoriskt godkännande för utökad omfattning av cellterapitillverkning för kliniska stadier

2025-04-11 10:00:00 SmartCella publicerar årsredovisning för 2024

2025-04-11 10:00:00 SmartCella publishes its 2024 Annual Report

2025-04-10 10:00:00 Kallelse till årsstämma i SmartCella Holding AB

2025-02-13 10:00:00 SmartCella tecknar avtal för vidareutveckling av professor Johan Ericsons forskning kring stamcellsbaserad behandling av Parkinsons sjukdom

2025-02-13 10:00:00 SmartCella enters agreement to advance Professor Johan Ericson’s research on cell replacement therapies for Parkinson’s disease

2024-11-12 09:00:00 SmartCella granted new European patent for the Extroducer delivery platform

2024-11-12 09:00:00 SmartCella beviljas nytt europeiskt patent för leveransplattformen Extroducer

2024-07-10 14:00:00 SmartCella tecknar licensavtal med XyloCor avseende Extroducer för att leverera genterapin XC001 till hjärtat 46143,62 SEK | +48,10%

2024-07-10 14:00:00 XyloCor and SmartCella enter into license agreement for use of the Extroducer to administer novel gene therapy XC001 to the heart 46143,62 SEK | +48,10%

2024-07-08 08:00:00 SmartCella tar in 50 miljoner euro för att accelerera tillväxt och kommersialisering

2024-07-08 08:00:00 SmartCella raises EUR 50 million to accelerate growth and commercialization

2024-06-12 09:00:00 Senior life science and medical specialists join SmartCella’s Board of Directors

2024-04-19 11:00:00 SmartCella strengthens team with Dr Ricardo Baptista as CTO

2024-04-11 10:05:41 CEO comments on the full year of 2023

2024-03-19 09:00:00 SmartCella AB appoints Oskar Steneryd as new CFO

2024-02-07 09:00:00 SmartCella obtains approval for GMP manufacturing and quality control testing of cell therapies

2024-01-03 11:00:00 SmartCella strengthens team by recruiting Dr. Nina Bauer as Chief Business Officer

2023-09-09 11:56:50 Q2 update on the SmartCella family

2023-05-11 09:00:00 Niklas Prager appointed new CEO of SmartCella

2023-05-11 09:00:00 Niklas Prager ny VD på SmartCella

2022-06-13 09:00:52 FDA approval for Smartwise Extroducer

2022-05-12 08:00:05 Procella published in Nature Cell Biology

2021-09-27 13:23:00 SmartCella Holding AB raises SEK 328 million to advance and accelerate development of the company's technologies

2018-05-07 16:03:00 ProCella Therapeutics and SmartWise enter collaboration with AstraZeneca to develop novel cardiovascular and catheter-based therapies

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode